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Abstract 
 Potential human and environmental hazards resulting from the exposure of living 
organisms to silver nanoparticles (Ag NPs) have been the subject of intensive discussion in the 
last decade. Despite the growing use of Ag NPs in biomedical applications, a quantification of 
the toxic effects as a function of the total silver mass reaching cells (namely, target cell dose) 
is still needed. To provide a more accurate dose-response analysis, we propose a novel 
integrated approach combining well-established computational and experimental 
methodologies. We first used the particokinetic model (ISD3) proposed by Thomas and 
colleagues (2018) for providing experimental validation of computed Ag NP sedimentation in 
static-cuvette experiments. After validation, ISD3 was employed to predict the total mass of 
silver reaching human endothelial cells and hepatocytes cultured in 96 well plates. Cell 
viability measured after 24h of culture was then related to this target cell dose. Our results 
show that the dose perceived by the cell monolayer after 24 h of exposure is around 85% 
lower than the administered nominal media concentration. Therefore, accurate dosimetry 
considering particle characteristics and experimental conditions (e.g., time, size and shape of 
wells) should be employed for better interpreting effects induced by the amount of silver 
reaching cells. 
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 Introduction 
Engineered nanomaterials (ENMs) are very successful in the bio-technology industry 
because of their exceptionally small size and unique physical and chemical properties 12,13. 
One of the most widely used ENMs is silver, popularly known for its antimicrobial properties. 
It can be coated on biomedical devices 9, used in medical contexts for personal health care 16 
or biological applications 35, and adapted for food products such as kitchen tools, storage 
containers and cutting boards 30. However, despite the growing use of silver nanoparticles (Ag 
NPs) in the last decade 1,7,25,43, potential human and environmental hazards resulting from 
exposure to Ag NPs continue to be the subject of attention 37,52 owing to their well-
documented toxicity both in vivo and in vitro.  
Le has succinctly discussed and summarised the increased exposure to Ag NPs and the 
possible effects related to their short- and long-term toxicity (e.g. decreased cell viability and 
apoptosis) 25. Well-established in vivo models 6,11,45, as well as in vitro systems 32,44,48, have 
been also proposed for toxicological studies. Mouse and zebrafish models exposed to ENMs, 
for example, showed nanotoxicity effects on female reproductive and fetal development 26,39. 
In vitro, dose-dependent Ag NPs induced cellular necrosis, inflammation and oxidative stress 
in living organisms in a size-specific manner 5,15,23,29,33,49. The oxidative stress was further 
related to the anti-microbial activity of Ag NPs affecting different types of pathogens 8,14,38. 
Genetic damage (e.g., DNA breakage) was additionally found within the cells interacting with 
Ag NPs 18 and associated with the production of reactive oxygen species 34,42. 
However, toxicity results are often misinterpreted since they are generally reported as a 
function of the initial silver nanoparticle concentration present in the culture medium (here 
referred to as nominal media concentration) and not as a function of that actually coming into 
contact with cells (i.e. target cell dose, here defined as the total mass of silver reaching cells, 
including ions and NPs, divided by the total volume of the media). At a given experimental 
time, this target cell dose is lower than the nominal media concentration because of NP 
transport (e.g. particle settling in static experiments, Brownian motion) and dissolution in the 
culture media before reaching cells. Only under ideal conditions (t → ) are the two 
concentrations equal. Therefore, in order to carry out more accurate dose-response analyses, 
minimizing animal testing and avoiding possible misleading conclusions, new computational 
10,27,31 and in vitro experimental methodologies 32,44,48 have been proposed. These approaches 
were subsequently combined for better describing the nanotoxicity induced by the direct 
interactions between Ag NPs and the biological components involved 3. In this paper we 
propose a novel integrated in vitro and in silico pipeline which combines experimental 
validation of Ag NP sedimentation and dissolution models with the computation of target cell 
dose (i.e. Ag NPs and dissolved Ag+ in cells) affecting the measured viability of a cell monolayer. 
Ag NP sedimentation measured in static-cuvette experiments was compared with theoretical 
values computed by the particokinetic model (ISD3) proposed by Thomas and colleagues 41. 
Having verified that the model correctly predicts the sedimentation process, we used it for 
estimating the total silver concentration perceived by human umbilical vein endothelial cells 
(HUVECs) and human hepatoma-derived immortalised hepatocyte C3A cells cultured in 96 
well plates. Finally, the cell viability was related to the computed target cell doses and 
compared to the nominal media concentrations of Ag NPs initially administered to cells. 
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Materials and Methods 
In vitro – in silico pipeline 
Figure 1 schematises the integrated in vitro – in silico pipeline used in this study. We first 
adapted the ISD3 model (Thomas et al 2018) to our experimental configuration (Fig. 1A). 
 
Figure 1. Particokinetics and experimental validation. (A) Graphical representation of Ag NP sedimentation, diffusion 
and dissolution in time as described by ISD3 (Thomas et al., 2018). (B) Nanoparticle sedimentation in static-cuvette 
experiments for model validation. (C) 96-well micro-plates experiments for evaluating cell toxicity induced by computed 
effective Ag NP doses. (D) Cell viability vs. computed target cell doses at time t. Notably, at a finite experimental time t, the 
computed target cell doses (here denoted with the apostrophe, i.e. X’, Y’ and Z’) are lower than their respective nominal 
media concentrations (i.e. X, Y and Z). 
Then we measured Ag NP sedimentation in static-cuvette experiments and compared the 
results with those computed by the model (Fig. 1B). In the next step, the model was used to 
estimate the target cell dose in 96-wells plated with cell monolayers (Fig. 1C). HUVEC and C3A 
cells were then cultured in 96-microwells and exposed to Ag NPs for up to 24 hours and the 
cell viability was related to the computed target cell doses as well as to the nominal media 
concentrations of Ag NPs administered to cells (Fig. 1D). 
Cell cultures 
Human umbilical vein endothelial cells (HUVECs) and human hepatoma-derived 
immortalised hepatocyte C3A cell line (ATCC Culture, USA) have been obtained by means 
approved by the appropriate ethical committees and used for evaluating nanotoxicity 44. 
Specifically, HUVECs were obtained as described in our previous work 44 and seeded at a 
concentration of 20,000 cells cm-2 on 1% w/v gelatin coated 96-well plates. Cells were allowed 
to reach confluence (typically 24 h) before exposure to Ag NPs. C3A hepatocytes were seeded 
at a density of 200,000 cells cm-2 on collagen coated plates and incubated for 24 h before 
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experiments. In view of conducting future co-culture experiments in a flow through system, 
the same medium was used for Ag NP exposure experiments for both HUVEC and hepatocytes. 
The cells were cultured in Eagle’s Minimum Essential Medium (EMEM, Lonza Bioscience, 
Basel, Switzerland), supplemented with 10% Fetal Bovine Serum (FBS, PAA, Pasching, Austria), 
1% Penicillin/Streptomycin/Amphotericin B, 2 mM L-Glutamine, 1% non-essential amino 
acids, 1% MEM vitamins solution (all from Lonza Bioscience, Basel, Switzerland), 10 µg mL-1 
Endothelial Cell Growth Supplement (ECGS), 10 ng mL-1 Human Epidermal Growth Factor 
(hEGF), 3 ng mL-1 basic Fibroblast Growth Factor (bFGF), 1 µg mL-1 Hydrocortisone, and 10 µg 
mL-1 Heparin Sodium Salt (all from Sigma-Aldrich, St. Louis, USA). 
Silver nanoparticles 
Ag NM300 from Ras GmbH, an OECD referenced nanomaterial (NM) with a nominal 
diameter of 20 nm sonicated in DMEM, was purchased as 10% w/w suspension in a aqueous 
solution containing 7% v/v ammonium nitrate as stabilizing agent and 4% v/v Tween 20 and 
4% v/v polyoxyethylene glycerol trioleate, as emulsifiers. The protocol developed by Klein et 
al. (2011) at the European Commission’s Joint Research Centre (JRC) and employed in several 
publications was used for a stock solution preparation 19,20. Ag NPs suspended in the medium 
were experimentally characterized as discussed by JRC (Klein et al., 2011), using the methods 
reported in Kermanizadeh 22 and Ucciferri (Ucciferri et al., 2014). The methods are 
summarised in the Supplementary Materials.  
Static sedimentation experiments 
A 2 mL quartz cuvette (Fig. 1B) was filled with the Ag NP suspension and corked to avoid 
evaporation. Sample absorbance was measured at 414 nm for up to 24 h using a Varian Cary 
UV spectrophotometer equipped with 1 mm hole positioned at half height of the cuvette. 
Detected nanoparticles were monitored at different nominal media concentrations (i.e. 5, 10, 
15, 40, 50, 80 µg mL-1). For each Ag NP concentration used, the absorbance at the beginning 
of the experiment (time 0 h) was used to generate a calibration curve.  
NP exposure and toxicity assay 
To assess Ag NP toxicity, the medium of HUVEC and C3A cells cultured in 96 -well plates 
(Fig. 1C) was replaced with 0.2 mL of medium containing homogeneously suspended Ag NPs 
at different concentrations (from 0 to 100 µg mL-1) at experimental time 0. Cells were then 
cultured for up to 24 h. To assess cell toxicity, medium containing Ag NPs or dispersant was 
removed after each incubation time, and fresh medium and Alamar reagent (CellTiter-Blue® 
Promega, Madison, USA) were added. Cell viability was obtained from the slope in 
fluorescence emission within a 2 h time frame measured with a plate-reader 
spectrophotometer (Omega-Fluostar Inc) and was expressed as a percentage with respect to 
cells exposed to 0 µg mL-1 Ag NP. For each particle concentration the interaction with the 
assay was finally tested in the absence of cells in order to check for any interference curve.  
In silico model 
We used the particokinetic model for predicting the silver concentration (in the form of 
Ag NPs and Ag+ ions) perceived by cells in a well. Briefly, ISD3 simulates diffusion and 
sedimentation of spherical nanoparticles in liquid media as well as the NP dissolution process. 
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It also models the cellular uptake of both Ag NPs and Ag+ ions in the system 41 (Fig. 1A). ISD3 
assumes that NPs are instantaneously taken up by cells when reaching their surface, while 
cell uptake of ions is explicitly modeled as a membrane diffusion process. Kinetics of uniformly 
distributed ions in liquid media and variations in ion concentrations due to surface adsorption 
and particle dissolution are finally simulated.  
The numerical approach underlying ISD3 is based on Stoke’s equation for modelling the 
sedimentation process and Fick’s law for describing the diffusion rate and the sedimentation 
velocity across the liquid media (Fig. 1A). The dissolution kinetics, estimated by fitting 
experimental data as a function of time in the medium of interest, are described in Figure 2 
and described in 41. Following the notation and definitions in Thomas et al 41, kf is the rate 
constant for the transfer of ions from the particle surface to the free ion state, kp the rate 
constant for the slow transfer of ions from the particle surface to the proteins, kp2 the rate 
constant for the initial fast transfer of silver ions from the particle surface to the protein-
bound state, kf2p the rate constant for the transfer of free ions from solution to the protein-
bound state, and kp2f the rate constant for the transfer of ions from the protein-bound state 
to the free ion state. 
 
Figure 2. Schematic of Ag NP dissolution process. The rate dissolution constants from Ag NPs to free ions (kf), protein 
(kp) and protein-bound NPs (kp2) are described in ISD3. The rate constants for the free ions in solution to protein-bound NPs 
(kf2p) and the transfer of ions from protein-bound NPs to free ions (kp2f) are also considered. 
Parameters required for running dose calculations, as well as the experimental 
approaches used for evaluating the input values and additional methods, are listed in Table 1 
and 2.  
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Table 1. List of ISD3 input parameters. 1) Liquid media characteristics; 2) protein-coated particle characteristics; 3) 
initial particle size distribution; 4) grid specification and boundary conditions; 5) time integration inputs. 
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Table 2. Additional ISD3 input parameters. Dissolution model inputs and Cellular uptake of silver ions. 
The input values used in 41 correspond to those for a nominal 20 nm silver nanomaterial 
in 10% serum. Hence, they are also suitable for Ag NMP300 in 10% FBS in the concentration 
range used in our studies (5-80 µg mL-1) and only a few values (shown in bold in Table 3) were 
modified for modelling the dissolution process involved in our static-cuvette and 96-well 
micro-plates. Should other particles be used, they must first be characterized using the 
methods suggested in Tables 1 and 2. 
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Table 3. Particokinetic model inputs. Parameters adapted for modelling dissolution processes in static-cuvette and 96-
well micro-plate experiments in this study are shown in bold. 
Data processing 
In order to evaluate sedimentation rates static-cuvette experiments were performed in 
duplicate, while 96-well plate in vitro experiments were performed in triplicate. Data were 
processed and the dose-response curves plotted using MATLAB R2013b (Mathworks). Results 
are expressed as means ± standard deviation. 
Results 
The Ag NPs used in this work have been extensively characterized (Klein et al., 2011; 
Kermanizadeh et al., 2013; Ucciferri et al., 2014) in the medium used in our experiments. The 
particles have an average size of 17.5 nm with euhedral morphology as measured using 
transmission electron microscopy (TEM). Finally, the mean effective diameter observed using 
Nanosight system is 120 nm with monomodal size distribution. Data are summarized in Table 
4. 
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Table 4. Ag NP characterization. Characterization performed by TEM and single particle tracking analysis (PTA) in the cell 
culture medium. 
Experimentally, we first tracked the Ag NP dissolution and sedimentation process in 
static-cuvette experiments as a function of the initial administered concentrations (nominal 
media concentrations). The rationale was to validate the particokinetic model ISD3 provided 
by Thomas et al. (2018) quantifying how the nano-particle concentrations computationally 
predicted by the model fit with those measured at half height of the cuvette (Fig. 3; grey bars). 
A high Pearson coefficient value (r=0.9991) was observed, indicating a strong correlation 
between predicted and detected concentrations (inset), confirming the reliability of the ISD3 
in modelling the particle sedimentation process. 
 
Figure 3. Validation of the particle sedimentation process in static-cuvette experiments. Ag NP concentrations at half 
height of the cuvette (grey bars) fit well with those predicted by the particokinetic model (black dashed line). The scatter 
plot (inset) shows a strong correlation (r = 0.9991) between the experimental and computed Ag NP concentrations. 
Subsequently, we compared the target cell doses predicted by the ISD3 model with 
increasing nominal media concentrations administered to HUVEC and C3A cells cultured in 
96-well micro-plates. The rationale was to test the assumption that the total silver 
concentrations coming into contact with the cellular system (i.e. the target doses) are lower 
than the nominal media concentrations because of the particle dissolution and sedimentation 
processes in media. In particular, we computed the target cell doses (Fig. 4A, solid lines) for 
different Ag NP nominal media concentrations (initially administrated to cells, dashed lines) 
over 24 hours. At the end of our experiment (24 h), the target cell doses were much lower 
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than their respective nominal media concentrations as represented by the vertical distance 
between the black and grey lines in Figure 4B. 
 
Figure 4. Target cell doses computed over 24 hours. (A) Target cell doses (solid lines) as a function of time and 
computed (dashed lines) from 6 nominal media concentrations (red: 0.5 µg mL-1; blue 1 µg mL-1; green 5 µg mL-1; grey 10 µg 
mL-1; cyan 50 µg mL-1; black 100 µg mL-1. Target cell doses are equal to zero at t = 0 (not apparent in the semi-log pot). (B) 
Target cell doses computed at t = 24 h (black solid line) versus nominal media concentrations. Notably, only under ideal 
conditions (t → ∞) are these two concentrations equal (grey solid line). The black dotted line denotes target cell doses at t = 
0 h, which are all null regardless of the nominal media concentration. 
The differences between them, here expressed as Δ = (nominal media concentration - 
target cell dose)/(nominal media concentration), are reported in Table 5. As expected, the 
target cell doses were proportional to their respective nominal media concentration (Table 
5). 
 
Table 5. Nominal media concentrations vs. Target cell doses. Target cell doses (i.e. Ag NPs and dissolved Ag+ in cells) 
are about 85% lower than their respective nominal media concentrations (i.e. the initial administered doses) at 24 h. 
These results demonstrate how the nanotoxicity potentially induced by the NP exposure 
could be misunderstood if related to the initial administered concentrations. Specifically, 
relating cell viability at a given experimental time to the nominal media concentration leads 
to an underestimation of the nanoparticle toxicity. Finally, no toxic effects were observed for 
Ag NP dispersant, nor did Ag NPs interfere with the viability assay (data not shown). 
Having evaluated the target cell doses during the entire exposure period (i.e., from 0 to 
24 h) and quantified differences with the nominal media concentrations (Δ values), we 
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measured HUVEC and C3A viability at 6 h (Fig. 5A), 16 h (Fig. 5B) and 24 h (Fig. 5C) of culture 
as a function of the computed target cell doses. 
 
Figure 5. HUVEC (gray line) and C3A (black line) viability as a function of increasing target cell doses. Panels show the 
viability as measured by the Alamar blue assay at 6 h (A), 16 h (B) and 24 h (C). Data shown as mean ± std (n=4). 
The rationale was to better interpret time-dependent nanotoxicity effects induced by the 
effective silver concentration coming into contact with cells. Both HUVEC (gray line) and C3A 
(black line) viability decreased with increasing target (and nominal) cell dose. From the graphs 
it is also evident that the Δ has implications on the estimation of IC50 values. In fact, referring 
to the nominal media concentration, the IC50 value at 24 h is estimated as   41.04 µg mL-1 
for HUVEC and 54.78 µg mL-1 for C3A. However, if one considers the target cell dose (actually 
experienced by cells), the IC50 drops significantly (~80%): 8.13 µg mL-1 for HUVEC and 10.95 
µg mL-1 for C3A. 
Discussion 
In this work we propose a novel integrated approach based on computational 
calculations and in vitro experiments to provide more accurate dose-response analyses and 
to minimize time-consuming, expensive and ethically sensitive in vivo tests 50. Having verified 
the accuracy of the ISD3 model through sedimentation experiments, we evaluated the 
viability of HUVEC and C3A cells cultured in 96-well plates as a function of the total silver mass 
reaching cells over time (namely, target cell dose). In this regard, much uncertainty still 
remains regarding which constituent (i.e., NPs, free and protein-bound ions) contributes to 
cellular toxicity 2,36. Bouwmeester and co-workers 4, as well as Wang and colleagues 47, 
suggest that exposure to silver ions formed extracellularly is responsible for observed toxic 
effects. Conversely, other groups assume that the internalized nanoparticles (i.e. NPs taken 
up by cells) undergo rapid dissolution resulting in silver ions inducing toxicity 17,40. The target 
cell dose includes both dissolved ions and particles coming into contact with cells (i.e. Ag NPs 
+ dissolved Ag+ in cells) and therefore can account for both NP and ion related toxic effects.  
Our results show that the target cell doses computed at 24 h were around 85% lower 
than their corresponding nominal media concentrations initially administered to cells (t=0 h). 
Moreover, both HUVEC and C3A viability decreased with concentration and with the time of 
exposure. Thus, Ag NP toxicity reported in the form of nominal dose-response data is likely to 
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be significantly underestimated, and the extent of error increases significantly at short 
exposure times.  
The present study highlights some fundamental concerns in in vitro nanotoxicology and 
suggests that a number of issues still need to be addressed before data from cell culture 
experiments can be considered reliable for predicting NP toxicity.  
As far as the model is concerned, for one it assumes the Ag NPs to be immediately 
absorbed once the cell surface is reached. Furthermore, ISD3 does not simulate the 
dissolution process of the Ag NPs once they have been taken up by the cells and it is limited 
to a 2 dimensional cell configuration, which is not considered “physiologically relevant”. By 
modelling the kinetics involved within the three-dimensional geometries of the cellular 
constructs, we should be able to predict the Ag NP uptake at multiple layers in a more realistic 
in vivo-like configuration. Moreover, the computed target cell doses sequentially absorbed 
“layer by layer” would allow an even more accurate analysis of the effects of nanotoxicity. In 
this regard, the three-dimensional and scaffold-less cellular aggregates in the form of 
“organoids”, “microtissues” or “spheroids” which resemble the cytoarchitectural 
arrangement of the human organs (e.g., liver, lung and specific brain regions) are currently 
being used as more physiologically relevant in vitro systems for experimental validation 28. 
For example, Kermanizadeh and co-workers have investigated three-dimensional human liver 
microtissue models, exposing them to different types of nanomaterials (including Ag NPs). 
They used Ag NP concentrations within the range employed here, demonstrating that their 
repeated exposure is more damaging to the liver tissue in comparison to a single exposure 21.  
In addition, for the model configuration described in our work, we would need to 
compute and experimentally validate not only the NPs diffusing towards the cells cultured on 
the bottom of the experimental set-up, but also those particles coming into contact with the 
cells possibly adjacent the walls. To the best of our knowledge, this second computational 
aspect has been exclusively provided by Bohemert and co-workers (2018). They indeed 
modelled the dosimetry and the exposure to nanoparticles of Caco-2 cells forming a confluent 
monolayer on the bottom of the cell culture dish, but also growing up the encircling wall of 
the cell culture dish 3. 
Another aspect to consider is that Ag NP sedimentation and cell toxicity were modelled 
and experimentally evaluated under static conditions. It would be interesting to extend the 
combined computational-experimental approach to dynamic experiments, implemented with 
a modular bioreactor similar to that described in our previous work 46 or a microfluidic system 
51. A multiphysics computational approach could be used to model the combined effects of 
particle sedimentation, diffusion, dissolution and convection as a function of the involved 
fluxes characterizing the dynamics of this type of more “physiologically relevant” in vitro 
model.  
Finally, it would be interesting to quantify the cell viability affected by absorbed 
nanoparticles of different materials and diameter sizes. These features, included the protein 
corona on the surface of the nanoparticles (in this work protein layer equal to (120-17.5) / 2 
= 51.25 nm), model the primary particle structure and specifically influence the induced 
nanotoxicity effects 3,41. 
In conclusion, the combination of computational and experimental approaches could 
provide more reliable dose-response analyses and hazard assessment. This study paves the 
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way for the development of a methodological framework which combines the expertise of 
modellers, toxicologists and scientists studying in nanotechnology and nanoscience to enable 
good experimental design and more accurate in vitro to in vivo data extrapolation. 
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Ag NP characterization 
Particles were dispersed in the complete cell culture medium. The same dispersion 
protocol was followed for all exposure experiments and when characterizing possible 
agglomeration tendencies and stability of dispersions. Ag NPs were stored as viscous liquid at 
the concentration of 10% (w/w) dispersed in water (75%) with a stabilizing agent (ammonium 
nitrate 7%) and emulsifiers (Tween 20 and polyoxyethylene glycerol trioleate, 4% each). For 
preparation of a stock solution we used the protocol provided by the ENPRA project 
(www.enpra.eu): ~100 mg of silver particle solution was weighed and dispersed in ~38 mL of 
water supplemented with 2% FBS to a final concentration of 2.56 mg mL-1.  Immediately 
after preparation the stock solution was sonicated for 16 min in an ultrasonic bath (Bandelin 
electronic, Berlin, Germany) at 200 W. Dilutions between 0 and 80 µg mL-1 were prepared in 
the complete cell culture medium. Before use samples were again sonicated for 15 min.  
Particle hydrodynamic diameter was determined via dynamic light scattering using 
Malvern Zeta sizer nano (Malvern Instruments, Herrenberg, Germany). Size and 
polydispersity were determined at time points 0, 1, 2, 4, 6, 8 and 24 hours after preparation 
of the respective dilution. Between measurements, dilutions were kept at room temperature 
and protected from light. Diluted samples were again sonicated for 16 minutes in an 
ultrasonic bath. For each time point, two independent samples were measured three times 
each and mean and standard deviation are reported.  
Size distribution and stability were also investigated using NanoSight LM10 instrument 
(NanoSight Limited, Amesbury, UK). The system is based on dynamic light scattering but uses 
single particle tracking analysis. At each time point, three measurements were performed; 
mean value and standard deviation were calculated. Here, sample data at 0, 8 and 24 h are 
reported (Figure S1). 
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Figure S1. Ag NPS tracking at 0 h, 8 h and 24 h.  
 
Running the ISD3 model 
The MATLAB code of ISD3 model is available from Thomas et al. (2018) and can be 
downloaded at https://nanodose.pnnl.gov. The boundary conditions of the experimental 
system can be easily updated by modifying the input data defined and discussed within the 
MATLAB script named “inputdata.m”. Right clicking and run the “isd3.m” file for beginning 
the simulations. Outputs are named as shown in Table S1 and saved into a MATLAB or EXCEL 
file. The name of this file can be entered into “inputdata.m” at line 48.  
 
 Table S1. List of the outputs generated by ISD3 particokinetic model and saved in an EXCEL file. The mass concentration 
of nanoparticles in liquid media vs. time and height x (i.e. output.tx_partConcL) is used for extracting the predicted Ag. NP 
concentration computed at half height of the cuvette (dashed line, Fig. 3). The target cell doses computed over 24 h (Fig. 4 
and 5) are obtained from the variables named output.t_partConcC and output.t_ionConcC which are saved into the EXCEL 
file as “CellDepositedParticleConc” and “CellIonConc”, respectively. 
 
